Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,327,345
+$109,635 QoQ
Shares Held
6,427
+2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,195
of 3,138 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Journey Advisory Group, LLC holds $51,629,041 across 8 Drug Manufacturers - General names. AMGN ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,437 | $25,712,183 | |
| 2 | ABBV |
AbbVie Inc.
|
47,472 | $11,945,854 | |
| 3 | JNJ |
Johnson & Johnson
|
25,892 | $6,575,791 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,149 | $2,974,646 | |
| 5 | AMGN |
Amgen Inc
This page
|
6,427 | $2,327,345 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,141 | $987,664 | |
| 7 | PFE |
Pfizer Inc
|
34,607 | $833,336 | |
| 8 | NVS |
Novartis AG
|
1,737 | $272,222 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,327,345 | 6,427 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,217,710 | 6,303 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,267,930 | 6,929 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $2,040,870 | 7,232 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,338,104 | 8,374 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,661,571 | 8,543 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,819,124 | 26,163 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $8,429,980 | 26,163 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,174,629 | 26,163 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $7,098,333 | 24,966 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,550,438 | 22,743 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,024,524 | 22,416 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,801,182 | 21,625 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,078,684 | 21,008 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $4,464,354 | 16,998 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,612,836 | 11,592 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,415,239 | 9,927 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,663,963 | 6,881 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,244,084 | 5,530 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $867,612 | 4,080 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $729,056 | 2,991 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $588,933 | 2,367 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $507,893 | 2,209 | Shares | Sole | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||